Vertex confirms supply chain continuity and business outlook for its cystic fibrosis medicines and provides initial update on development programs

Vertex confirms supply chain continuity and business outlook for its cystic fibrosis medicines and provides initial update on development programs.vertex pharmaceuticals inc - confirmed its 2020 business outlook.vertex pharmaceuticals inc - made proactive changes to some of ongoing and planned clinical trials.vertex pharmaceuticals inc - too early to precisely determine long-term effects of outbreak on trial timelines..vertex pharmaceuticals inc - has ample supply to meet commercial needs well into future.vertex pharmaceuticals inc - remains highly confident in its ability to continue to supply all of its medicines to patients around world.vertex pharmaceuticals inc - manufacturing facilities have remained operational and continue to produce new supply of company's medicines..vertex pharmaceuticals - for ongoing studies, co is working with clinical trial sites to enable virtual clinic visits and home delivery of study drug.vertex pharmaceuticals inc - vertex will temporarily pause enrollment in certain studies and may delay some new study starts..
VRTX Ratings Summary
VRTX Quant Ranking